beraprost and Burns

beraprost has been researched along with Burns* in 3 studies

Other Studies

3 other study(ies) available for beraprost and Burns

ArticleYear
Beraprost sodium: a stable prostaglandin I2 analogue.
    British journal of plastic surgery, 1997, Volume: 50, Issue:1

    Topics: Adult; Animals; Burns; Epoprostenol; Graft Survival; Humans; Male; Platelet Aggregation Inhibitors; Rats; Surgical Flaps

1997
Effect of a prostaglandin I2 analogue, beraprost sodium, on burn-induced gastric mucosal injury in rats.
    Burns : journal of the International Society for Burn Injuries, 1997, Volume: 23, Issue:3

    Stress ulcers still have a high mortality in critically burned patients and the pathophysiology remains relatively unknown. Impaired gastric mucosal perfusion is one of the factors contributing to gastric mucosal ulceration. Burn injury causes thrombosis and vascular occlusion by increasing the blood viscosity, resulting in decreased organ perfusion. Reduced blood flow is one of the most important factors in gastric mucosal ulceration. Beraprost sodium is a chemically stable prostaglandin I2 (PGI2) analogue with antiplatelet, vasodilator and cytoprotective actions. In the present study, we examined the effects of a PGI2 analogue, beraprost sodium (Procylin, Kaken Pharmaceutical Company, Tokyo, Japan) on burn-induced gastric mucosal changes in rats. Twenty male Sprague-Dawley rats weighing an average of 400 g were burned with hot water (90 degree C) and then divided into two groups of 10 animals. One group received 0.015 mg of beraprost sodium intraperitoneally immediately after burn injury, while the control group received the same volume of saline. Gastric mucosal blood flow was measured with a laser Doppler flowmeter and the area of mucosal necrosis was also determined macroscopically and histologically. Gastric mucosal damage was significantly reduced in the beraprost sodium-treated rats and gastric mucosal blood flow was significantly improved (p < 0.05). These findings demonstrate that PGI2 plays a very important role in the pathophysiology of burn-induced Curling's ulcer and that beraprost sodium can improve gastric mucosal blood flow and reduce mucosal damage.

    Topics: Animals; Blood Flow Velocity; Burns; Disease Models, Animal; Epoprostenol; Gastric Mucosa; Laser-Doppler Flowmetry; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Physiological; Vasodilator Agents

1997
Reduction of progressive burn injury by a stable prostaglandin I2 analogue, beraprost sodium (Procylin): an experimental study in rats.
    Burns : journal of the International Society for Burn Injuries, 1996, Volume: 22, Issue:7

    Beraprost sodium is a chemically stable prostaglandin I2 analogue with antiplatelet and vasodilator actions. Burn injury causes thrombosis and vessel occlusion by increasing the blood viscosity and by thermal damage to the vascular network in the dermis. A vascular response also occurs in the uninjured dermis surrounding the site of injury. Diminished blood flow and spreading tissue oedema lead to progressive ischaemia and necrosis around the burn site (zone of stasis), with the final necrotic tissue area being larger than the initial one. If blood flow could be restored in the zone of stasis, secondary tissue damage would be minimized. In this study, we examined the effects of a prostaglandin I2 analogue, beraprost sodium (Procylin, Kaken Pharmaceutical Company, Tokyo, Japan) on burn injury in rats. Twenty male Sprague-Dawley rats weighing an average of 450 g were burned with a comb-shaped brass probe that produced a row of three burns measuring 10 x 30 mm each and two intervening unburned areas measuring 5 x 30 mm each. The rats were divided into two groups of 10 animals. One group received 0.015 mg of beraprost sodium intraperitoneally immediately after burn injury, while the control group received the same volume of saline. Skin blood flow was measured with a laser Doppler flowmeter, and the development of oedema as well as the area of necrotic tissue were also determined. The extent of skin necrosis and oedema were significantly reduced in the beraprost sodium-treated rats, and blood flow in the zone of stasis was increased. These findings demonstrate that prostaglandin I2 plays an important role in burn injury and that beraprost sodium can reduce secondary necrosis in the zone of stasis.

    Topics: Animals; Biopsy, Needle; Burns; Disease Models, Animal; Dose-Response Relationship, Drug; Epoprostenol; Hemodynamics; Injections, Intraperitoneal; Male; Necrosis; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Reference Values; Regional Blood Flow; Skin; Treatment Outcome

1996